TMLEP Clinical Updates
TMLEP’s Clinical Updates are provided in order to raise awareness of clinical risk issues and to reduce incidence recurrence and improve patient safety. Facts have been anonymised to maintain data confidentiality, however learning points remain applicable.
To receive notifications as soon as new updates become available, please enter your details in the form below or follow TMLEP’s Twitter or LinkedIn feeds (accessible at the top of the page).
-
The Importance of Early Action in Sepsis Management with Paediatrics
22 September 2021Sepsis can lead to a range of complications. Most critically, it is commonly fatal, particularly if the diagnosis is delayed, or in patients with other significant health problems. Early recognition and interventions as above will give patients the best chance of survival.
-
The Importance of Cautious Monitoring of the Fluid Balance in Patients with Acute Kidney Injury
08 September 2021Acute kidney injury (AKI) is now the preferred term for what used to be called “acute renal failure”. It is defined by an acute change in kidney function determined either by changes in the serum creatinine or reduction in the urine output into the oliguria range.
-
Managing Hyponatraemia
24 August 2021It is imperative that if hyponatraemia is suspected or diagnosed that clinicians provide appropriate care by arranging appropriate investigations, arranging a referral to an appropriate specialist such as an endocrinologist and/or admitting the patient to hospital for treatment.
-
Undertaking Caudal Epidural in Patients on Rivaroxaban
04 August 2021Caudal epidural injections run the risks of infection, bleeding, nerve injury and intraspinal injection. These risks are higher when patients are on antiplatelet agents and Rivaroxaban, and such should be considered with the patient during the consenting process.